For meetings and deliveries:
12 Veterans Square
1st Floor Left
Media, PA 19063 U.S.A.
P.O. Box 209
Swarthmore, PA 19081-0209 U.S.A.
Phone: (610) 892-9942
Twitter: @TechLaw_Elman and @ElmanTechNews
eFax: (925) 226-4995
- The Medicines Company v. Hospira: When Does Outsourcing Drug Manufacture to a Third-Party Contractor Trigger an On-Sale Bar to Patentability?
- Patenting Decisions by South African Biotechnology Entrepreneurs
- Patenting Genes in China, the U.S., and the EU: How Does It Differ? Could It Get Out of Control?
Patent Attorney & Attorney at Law
M.P. is a patent attorney registered with the United States Patent and Trademark Office. He received his J.D. degree in December 2006 from Widener University School of Law in Wilmington, Delaware. In May 2007, he was admitted as an attorney at law in Pennsylvania.
M.P. earned a Ph.D. degree in organic chemistry from Virginia Polytechnic Institute and State University. He has had several years experience as a synthetic organic chemist researcher with DuPont’s crop protection business.
He has served as a Patent Examiner at the U.S. Patent and Trademark Office.
M.P. also holds memberships in the American Chemical Society, the American Intellectual Property Law Association, the Patent Information User Group and participates in the activities of the Benjamin Franklin American Inn of Court and the DelCo IP Forum.
≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈ ≈
- Thank You to TPNG for hosting Gerry Elman and Joshua Waterston’s presentation “Cybersecurity Technical and Legal Challenges (You Can’t Just Check the Box)”
- Gerry Elman is listed in The Best Lawyers in America© in Technology Law
- Sept. 22, 2016 our Elman & Waterston to speak on Cybersecurity Technical and Legal Challenges (You Can’t Just Check the Box) at TPNG meeting in Philadelphia area
- American Bar Ass’n to distribute FBI cyber-threat warnings
- In McRO, Federal Circuit Provides Further Guidance on Section 101
- Court of Appeal Upholds Construction of the Promise Distinguishing Between the Compounds and Use Claims
- Two Panel Court Of App EAL Does Not Have Subject-Matter Jurisdiction In this Case to Vary Its Three Panel Judgment
- Apotex to Supreme Court: Review BPCIA 180-Day Notice Requirement
- Court of Appeal Upholds Finding of Infringement and Only Requires a "Mere Scintilla" of Utility
- Trial Judge Acknowledges Stare Decisis and Comity In Relation To Findings from the Previous NOC Proceedings